HUTCHMED (China) Limited (HCM)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$13.43
-0.15%
Mkt Cap $2.49B
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$17.50
Range $17.50 – $17.50
Implied Upside
+30.3%
Consensus $17.50 vs current $13.43